HeartSciences Inc.
HSCS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $8 | $4 | $4 | $3 |
| - Cash | $1,951 | $3 | $1 | $3 |
| + Debt | $876 | $2 | $3 | $3 |
| Enterprise Value | -$1,066 | $3 | $6 | $4 |
| Revenue | $2 | $0 | $0 | $0 |
| % Growth | 127,215.8% | -56.3% | – | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 58.3% | 60% | 56.8% | – |
| EBITDA | -$2,073 | -$2 | -$2 | -$2 |
| % Margin | -85,713.2% | -96,822.7% | -43,269.4% | – |
| Net Income | -$2,351 | -$2 | -$2 | -$2,536 |
| % Margin | -97,179.4% | -108,157.6% | -48,145.5% | – |
| EPS Diluted | -0.85 | -1.58 | -1.88 | -2.57 |
| % Growth | 46.2% | 16% | 26.8% | – |
| Operating Cash Flow | -$2,334 | -$2 | -$2 | -$2 |
| Capital Expenditures | -$13 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2,347 | -$2 | -$2 | -$2 |